Page last updated: 2024-08-24

plerixafor and Brucellosis

plerixafor has been researched along with Brucellosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arayan, LT; Huy, TXN; Kang, CK; Kim, S; Lee, HJ; Lee, JH; Min, W; Reyes, AWB; Vu, SH1

Other Studies

1 other study(ies) available for plerixafor and Brucellosis

ArticleYear
Chemokine receptor 4 (CXCR4) blockade enhances resistance to bacterial internalization in RAW264.7 cells and AMD3100, a CXCR4 antagonist, attenuates susceptibility to Brucella abortus 544 infection in a murine model.
    Veterinary microbiology, 2019, Volume: 237

    Topics: Animals; Benzylamines; Brucella abortus; Brucellosis; Cell Survival; Cyclams; Disease Susceptibility; Female; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Models, Biological; RAW 264.7 Cells; Receptors, CXCR4; Specific Pathogen-Free Organisms

2019